Daxor Corp
NASDAQ:DXR
Net Margin
Daxor Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Daxor Corp
NASDAQ:DXR
|
46.6m USD |
451%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.7B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
184.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
152.5B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.5B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
109B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.8B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.9B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.4B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
272.6B CNY |
31%
|
Daxor Corp
Glance View
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Daxor Corp's most recent financial statements, the company has Net Margin of 451.1%.
You don't have any saved screeners yet